LIDOCAÏNE KABI 10 mg/ml, solution for injection 100 ampoules of 5 ml
Active ingredients: Lidocaine, Lidocaine hydrochloride
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection100 ampoules of 5 mlinfiltration;intramusculaire;intraveineuse;péridurale;périneurale;sous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LIDOCAÏNE KABI 10 mg/mL, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- infiltration;intramusculaire;intraveineuse;péridurale;périneurale;sous-cutanée
- Presentation description
- 100 ampoules polyéthylène basse densité (PEBD) de 5 mL
- Marketing authorisation holder
- FRESENIUS KABI FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 15 Feb 2022
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62793992CIP75505689CIP133400955056898Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LIDOCAÏNEsolution | 8,11 mg · 1 mL de solution | FT |
| LIDOCAÏNE (CHLORHYDRATE DE) MONOHYDRATÉsolution | 10 mg · 1 mL de solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.